AI drug designer Insilico Medicine aims to generate nearly $300M in Hong Kong IPO Fierce Biotech Nawigacja wpisu Eli Lilly, Novo Nordisk file new weight-loss drugs that could be game changers in obesity medicine – MarketWatch Detection of undiagnosed liver cirrhosis via AI-enabled electrocardiogram: a pragmatic, cluster-randomized clinical trial – Nature
